#ICS2014 - Poster: Clinical and quality of life outcomes in male non‐neurogenic overactive bladder managed with intra‐detrusor botulinum toxin type A: An 8 year experience

RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by Giovanni Losco, David Habashy, Vincent Tse, Ruth Collins, and Lewis Chan at the International Continence Society (ICS) 2014 Annual Meeting - October 20 - 24, 2014 - Rio de Janeiro, Brazil

There is a paucity of data on clinical outcomes of men with drug-­refractory non-­neurogenic overactive bladder (NNOAB) managed with intradetrusor botulinum toxin type A (BTXA) injections...

¹Department of Urology, Concord Repatriation General Hospital, Sydney, Australia